Applicant, as named in the Orange Book

Vertex Pharms

Next listed expiry: Kalydeco on 13 Feb 2030. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Kalydeco ivacaftor	ivacaftor	203188	13 Feb 2030	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.